Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function

被引:171
作者
Ahmed, SH [1 ]
Koob, GF
机构
[1] Univ Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, F-33076 Bordeaux, France
[2] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92103 USA
关键词
reward; reinforcement; self-administration; self-medication; self-regulation; dopamine; cocaine; laboratory environment;
D O I
10.1007/s00213-005-2180-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: The transition from initial drug use to drug addiction has been proposed to result from an allostatic decrease in reward function driven by an over-activation of brain antireward processes. Objectives: How decreased reward function explains compulsive drug use is not entirely clear at present, and is still a subject for debate. Methods: We present a quantitative model of cocaine self-administration that integrates pharmacokinetic, pharmacodynamic, and motivational factors to address this question. The model assumes that reward system responsivity is a homeostatically regulated process where the desired level of responsivity ( called the reward set point) is initially different from the baseline level. The reduction or correction of this difference or error in reward function would drive cocaine self-administration. Results: Theoretical data obtained by computer simulation fit the experimental data obtained in animals self-administering cocaine (i.e.,the within-session pattern of self-injections, the shape and curvature of the dose-injection function, the nonlinear relationship between drug intake and regulated drug effects). Importantly, simulation of an allostatic decrease in reward system responsivity exacerbates the initial error that drives self-administration, thereby increasing both the intake of, and the motivation for, the drug. This allostatic change manifests as a vertical shift in the dose-injection function similar to that seen in animals with escalating cocaine self-administration. Conclusions: The present model provides a satisfactory explanation of escalated drug intake and suggests a novel negative reinforcement view of addiction based on an allostatic decrease in reward function.
引用
收藏
页码:473 / 490
页数:18
相关论文
共 126 条
  • [1] Transition from moderate to excessive drug intake: Change in hedonic set point
    Ahmed, SH
    Koob, GF
    [J]. SCIENCE, 1998, 282 (5387) : 298 - 300
  • [2] Long-lasting increase in the set point for cocaine self-administration after escalation in rats
    Ahmed, SH
    Koob, GF
    [J]. PSYCHOPHARMACOLOGY, 1999, 146 (03) : 303 - 312
  • [3] Neuroscience - Addiction as compulsive reward prediction
    Ahmed, SH
    [J]. SCIENCE, 2004, 306 (5703) : 1901 - 1902
  • [4] Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels
    Ahmed, SH
    Lin, D
    Koob, GF
    Parsons, LH
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 86 (01) : 102 - 113
  • [5] Neurobiological evidence for hedonic allostasis associated with escalating cocaine use
    Ahmed S.H.
    Kenny P.J.
    Koob G.F.
    Markou A.
    [J]. Nature Neuroscience, 2002, 5 (7) : 625 - 626
  • [6] Persistent increase in the motivation to take heroin in rats with a history of drug escalation
    Ahmed, SH
    Walker, JR
    Koob, GF
    [J]. NEUROPSYCHOPHARMACOLOGY, 2000, 22 (04) : 413 - 421
  • [7] OPIATE ADDICTION - THE CASE FOR AN ADAPTIVE ORIENTATION
    ALEXANDER, BK
    HADAWAY, PF
    [J]. PSYCHOLOGICAL BULLETIN, 1982, 92 (02) : 367 - 381
  • [8] The biological, social and clinical bases of drug addiction: Commentary and debate
    Altman, J
    Everitt, BJ
    Glautier, S
    Markou, A
    Nutt, D
    Oretti, R
    Phillips, GD
    Robbins, TW
    [J]. PSYCHOPHARMACOLOGY, 1996, 125 (04) : 285 - 345
  • [9] Bardo MT, 2001, PSYCHOPHARMACOLOGY, V155, P278
  • [10] Evidence for bidirectional cues as a function of time following treatment with amphetamine: implications for understanding tolerance and withdrawal
    Barrett, RJ
    Caul, WF
    Smith, RL
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 79 (04) : 761 - 771